HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Cao Selected Research

Antigens

10/2016Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.
4/2009Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection.
8/2001RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis.
12/2000[Human Fab antibodies derived from phage display library neutralize hepatitis A virus in vitro].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Cao Research Topics

Disease

28Neoplasms (Cancer)
04/2022 - 11/2000
10Infections
04/2022 - 12/2000
9Inflammation (Inflammations)
10/2020 - 03/2007
8Neoplasm Metastasis (Metastasis)
06/2018 - 11/2000
6Hypoxia (Hypoxemia)
10/2020 - 08/2000
6Colorectal Neoplasms (Colorectal Cancer)
10/2019 - 04/2001
5Breast Neoplasms (Breast Cancer)
11/2020 - 06/2001
5Necrosis
11/2016 - 06/2008
5Carcinoma (Carcinomatosis)
05/2012 - 12/2000
4Heart Failure
01/2022 - 01/2018
4Hepatocellular Carcinoma (Hepatoma)
11/2015 - 05/2011
4Squamous Cell Carcinoma of Head and Neck
01/2004 - 11/2000
4Hypersensitivity (Allergy)
12/2001 - 11/2000
3Lymphatic Metastasis
02/2021 - 11/2010
3Chronic Obstructive Pulmonary Disease (COPD)
10/2020 - 03/2015
3Hypertension (High Blood Pressure)
08/2019 - 11/2015
3Malaria
07/2018 - 10/2016
3Kashin-Beck Disease
07/2014 - 06/2008
3Lung Neoplasms (Lung Cancer)
10/2013 - 12/2000
3Dental Fluorosis
06/2001 - 09/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2022 - 09/2013
2Diabetes Mellitus
01/2022 - 04/2020
2Shock
01/2022 - 07/2003
2Congenital Abnormalities (Deformity)
12/2021 - 03/2015
2Venous Thrombosis (Deep-Vein Thrombosis)
04/2021 - 06/2018
2Triple Negative Breast Neoplasms
11/2020 - 01/2018
2Body Weight (Weight, Body)
05/2020 - 02/2018
2Atrial Fibrillation
11/2019 - 05/2016
2Pain (Aches)
03/2019 - 09/2001
2Papillary Thyroid Cancer
01/2019 - 10/2014
2Ischemic Stroke
12/2018 - 06/2013
2Prostatic Neoplasms (Prostate Cancer)
12/2018 - 02/2001
2Leukemia
06/2018 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 09/2013
2Insulin Resistance
01/2017 - 09/2011
2Hemorrhage
05/2016 - 02/2000
2Hyperplasia
06/2015 - 03/2001
2Retinoblastoma (Glioblastoma, Retinal)
09/2013 - 08/2001
2Disease Progression
06/2013 - 12/2000
2Substance-Related Disorders (Drug Abuse)
04/2013 - 02/2001
2Colonic Neoplasms (Colon Cancer)
03/2012 - 02/2001
2Melanoma (Melanoma, Malignant)
03/2012 - 02/2001
2Adenocarcinoma
01/2012 - 03/2010
2Carcinogenesis
01/2012 - 03/2001

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
04/2021 - 06/2000
8CytokinesIBA
10/2020 - 12/2000
6Biological ProductsIBA
01/2018 - 07/2001
6Messenger RNA (mRNA)IBA
06/2015 - 03/2001
6DNA (Deoxyribonucleic Acid)IBA
05/2012 - 12/2000
5Biomarkers (Surrogate Marker)IBA
04/2021 - 12/2000
5Pharmaceutical PreparationsIBA
11/2019 - 12/2000
5EnzymesIBA
01/2019 - 08/2001
4AntigensIBA
10/2016 - 12/2000
4FluoridesIBA
09/2001 - 01/2001
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2001
3DiureticsIBA
01/2022 - 08/2019
3Therapeutic UsesIBA
12/2021 - 12/2014
3NF-kappa B (NF-kB)IBA
10/2020 - 12/2015
3MicroRNAs (MicroRNA)IBA
10/2020 - 01/2013
3Immunoglobulin G (IgG)IBA
04/2020 - 12/2000
3CollagenIBA
07/2018 - 05/2011
3AntioxidantsIBA
01/2018 - 11/2008
3Small Interfering RNA (siRNA)IBA
01/2017 - 11/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 09/2006
3Matrix Metalloproteinases (MMPs)IBA
06/2001 - 12/2000
3Picryl Chloride (Trinitrochlorobenzene)IBA
05/2001 - 11/2000
2GlucocorticoidsIBA
04/2022 - 04/2020
2AminoglycosidesIBA
01/2022 - 12/2001
2Immunoglobulins (Immunoglobulin)IBA
10/2020 - 04/2001
2Chimeric Antigen ReceptorsIBA
01/2020 - 06/2018
2Protons (Proton)IBA
04/2019 - 03/2010
2Hematoxylin (Haematoxylon)IBA
12/2018 - 06/2008
2Eosine Yellowish-(YS) (Eosin)IBA
12/2018 - 06/2008
2SmokeIBA
08/2018 - 04/2013
2Protamines (Protamine Sulfate)FDA Link
06/2018 - 06/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2018 - 12/2000
2Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 01/2001
2CateninsIBA
01/2018 - 11/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 01/2001
2AdiponectinIBA
11/2016 - 09/2011
2Monoclonal AntibodiesIBA
10/2016 - 12/2000
2CorticosteroneIBA
08/2016 - 07/2003
2UbiquitinIBA
01/2016 - 05/2011
2OsteopontinIBA
01/2016 - 11/2015
2Histones (Histone)IBA
11/2015 - 06/2000
2Chemokine ReceptorsIBA
04/2015 - 09/2013
2salicylhydroxamic acid (SHAM)IBA
12/2014 - 01/2014
2Telomerase (Telomerase Reverse Transcriptase)IBA
10/2014 - 03/2001
2ORALIT (ORS)IBA
07/2014 - 09/2013
2Proteoglycans (Proteoglycan)IBA
07/2014 - 06/2008
2Collagen Type I (Type I Collagen)IBA
05/2011 - 05/2001

Therapy/Procedure

13Therapeutics
04/2022 - 03/2000
6Drug Therapy (Chemotherapy)
02/2021 - 12/2000
4Transplantation
04/2022 - 09/2000
4Length of Stay
04/2022 - 12/2016
2Enhanced Recovery After Surgery
04/2022 - 12/2021
2Ligation
01/2022 - 01/2014
2Artificial Respiration (Mechanical Ventilation)
10/2020 - 03/2017
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2020 - 11/2019
2Stents
12/2019 - 01/2017